Delivery Order SPE2DE22D0008-SPE2D626F27DE
Award Date 1/27/26
Potential Completion Date 1/30/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,080 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-E monoclonal antibodies under a firm fixed price contract. The award, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, represents a competitive procurement with no set-aside designation. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,422.00 delivery order contract to Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics specializing in in vitro diagnostic products and blood banking materials. The award, issued on December 12, 2025, with an ultimate completion date of December 17, 2025, is for ALBACLONE Anti-A monoclonal antibodies used in blood typing and immunohematology testing. This firm fixed-price delivery order carries no...
- Alba Bioscience, Inc. was awarded a $7,303 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on January 6, 2026, with an ultimate completion date of January 9, 2026. The contract, issued without set-aside designation, covers ALBACLONE Anti-S (Big S) monoclonal antibodies and related immunohematology reagents for blood banking and transfusion services. Performance will be executed from the contractor's facility in Chicago, Illinois. This delivery...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,115.79 to Alba Bioscience, Inc. for the ALBACYTE Antibody ID Panel (16-Cell) on October 30, 2025, with an ultimate completion date of January 7, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier of immunohematology reagents and blood banking diagnostic materials. Alba Bioscience, a...
- Alba Bioscience, Inc., a Chicago-based diagnostic supplier specializing in immunohematology reagents and blood banking materials, was awarded a $4,740 delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 30, 2025, for ALBACLONE Anti-B monoclonal antibodies. The contract, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by November 4, 2025, and will be performed in Chicago, Illinois. This delivery order represents a...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded Alba Bioscience, Inc. a $9,500 delivery order on October 30, 2025, for an ALBACYTE Antibody ID Panel (10-Cell) with a completion date of January 7, 2026. This firm fixed-price delivery order represents a competitive procurement without set-aside designation, leveraging Alba Bioscience's specialized capabilities in immunohematology reagents and blood banking diagnostics. Alba Bioscience, a Chicago-based subsidiary of...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,400 firm fixed-price delivery order to Alba Bioscience, Inc. on January 23, 2026, for ALBACYTE IgG sensitized cells II, with completion scheduled for March 30, 2026. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and blood banking materials to federal healthcare systems. The contract was awarded without set-aside designation, reflecting...
- Alba Bioscience, Inc. was awarded a delivery order valued at $6,270 on September 4, 2025, for the ALBACYTE Antibody ID Panel (10-Cell) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The contract is scheduled for completion by November 7, 2025, and will be performed at the contractor's facility in Chicago, Illinois. This non-set-aside award represents Alba Bioscience's continued role as a critical supplier of specialized in vitro diagnostic...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,150 to Alba Bioscience, Inc. for ALBACYTE Antibody Screen (2-Cell) products, with an ultimate completion date of October 9, 2025. Alba Bioscience, a Chicago-based supplier of in vitro diagnostics and blood bank reagents, was selected through a non-set-aside competitive process. The delivery order falls under the company's existing blanket purchase agreements with the Department of Veterans Affairs, which...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and quality control materials to various U.S. government agencies. The contract, valued at $22,621.60, is a delivery order for "ALBACLONE ANTI-D BLEND" products. It is a firm fixed-price contract with a period of performance ending on...